Interim statement of the COVID-19 subcommittee of the WHO Global Advisory Committee on vaccine safety on AstraZeneca COVID-19 vaccine.
出版信息
Saudi Med J. 2021 May;42(5):581-582.
Abstract
摘要
相似文献
1
2
The role of anti-platelet factor 4 antibodies and platelet activation tests in patients with vaccine-induced immune thrombotic thrombocytopenia: Brief report on a comparison of the laboratory diagnosis and literature review.抗血小板因子 4 抗体和血小板活化试验在疫苗诱导免疫性血栓性血小板减少症患者中的作用：实验室诊断比较及文献复习简要报告。
Clin Chim Acta. 2022 Apr 1;529:42-45. doi: 10.1016/j.cca.2022.02.003. Epub 2022 Feb 12.
3
Unusual Fever, Headache, and Abdominal Pain in a Healthy Woman.一名健康女性出现的异常发热、头痛和腹痛
Gastroenterology. 2021 Nov;161(5):1387-1389. doi: 10.1053/j.gastro.2021.07.039. Epub 2021 Jul 31.
4
Effect of Pfizer/BioNTech and Oxford/AstraZeneca vaccines against COVID-19 morbidity and mortality in real-world settings at countrywide vaccination campaign in Saudi Arabia.辉瑞/生物科技和牛津/阿斯利康疫苗对沙特阿拉伯全国疫苗接种运动中真实环境下 COVID-19 发病率和死亡率的影响。
Eur Rev Med Pharmacol Sci. 2021 Nov;25(22):7185-7191. doi: 10.26355/eurrev_202111_27271.
5
COVID-19 vaccines surveillance in France: a global response to a major national challenge.法国的新冠疫苗监测：对一项重大国家挑战的全球应对。
Anaesth Crit Care Pain Med. 2021 Jun;40(3):100866. doi: 10.1016/j.accpm.2021.100866. Epub 2021 Apr 22.
6
Generalized Edema and Pseudothrombocytopenia After ChAdOx1 nCoV-19 COVID-19 Vaccination: A Case Report.接种 ChAdOx1 nCoV-19 新冠疫苗后出现全身性水肿和假性血小板减少症：1 例病例报告。
Front Public Health. 2022 May 27;10:907652. doi: 10.3389/fpubh.2022.907652. eCollection 2022.
7
Bullous Sweet syndrome following SARS-CoV-2 Oxford AstraZeneca vaccine.新型冠状病毒牛津阿斯利康疫苗接种后出现的大疱性斯威特综合征。
Br J Dermatol. 2022 Mar;186(3):e110. doi: 10.1111/bjd.20876. Epub 2021 Nov 24.
8
Inverse lichen planus post Oxford-AstraZeneca COVID-19 vaccine.牛津-阿斯利康新冠疫苗接种后出现的扁平苔藓样疹
J Cosmet Dermatol. 2022 Mar;21(3):883-885. doi: 10.1111/jocd.14738. Epub 2022 Jan 8.
9
Possible Risk of Thrombotic Events following Oxford-AstraZeneca COVID-19 Vaccination in Women Receiving Estrogen.接受雌激素治疗的女性接种牛津-阿斯利康 COVID-19 疫苗后发生血栓栓塞事件的可能风险。
Biomed Res Int. 2021 Oct 25;2021:7702863. doi: 10.1155/2021/7702863. eCollection 2021.
10
Immune response and safety of heterologous ChAdOx1-nCoV-19/mRNA-1273 vaccination compared with homologous ChAdOx1-nCoV-19 or homologous mRNA-1273 vaccination.异源 ChAdOx1-nCoV-19/mRNA-1273 疫苗接种与同源 ChAdOx1-nCoV-19 或同源 mRNA-1273 疫苗接种的免疫反应和安全性比较。
J Formos Med Assoc. 2022 Apr;121(4):766-777. doi: 10.1016/j.jfma.2022.02.020. Epub 2022 Mar 16.
引用本文的文献
1
Management and Characteristics of Embolism and Thrombosis After COVID-19 Vaccination: Scoping Review.新冠疫苗接种后栓塞与血栓形成的管理及特征：范围综述
J Multidiscip Healthc. 2023 Sep 20;16:2745-2772. doi: 10.2147/JMDH.S421291. eCollection 2023.
2
The winding 12-month journey of the AstraZeneca COVID-19 vaccine since its first administration to humans.阿斯利康 COVID-19 疫苗从首次给人类接种到现在已经过去了 12 个月的曲折历程。
Therapie. 2023 May-Jun;78(3):293-302. doi: 10.1016/j.therap.2022.07.003. Epub 2022 Jul 13.
3
COVID-19 Vaccine: Side Effects After the First Dose of the Oxford AstraZeneca Vaccine Among Health Professionals in Low-Income Country: Ethiopia.新冠疫苗：低收入国家埃塞俄比亚卫生专业人员接种第一剂牛津阿斯利康疫苗后的副作用
J Multidiscip Healthc. 2021 Sep 16;14:2577-2585. doi: 10.2147/JMDH.S331140. eCollection 2021.
4
Cancer or COVID-19? A Review of Recommendations for COVID-19 Vaccination in Cancer Patients.癌症还是 COVID-19？癌症患者 COVID-19 疫苗接种建议的综述。
Curr Treat Options Oncol. 2021 Sep 13;22(10):95. doi: 10.1007/s11864-021-00903-7.
5
A reasoned approach towards administering COVID-19 vaccines to pregnant women.对向孕妇接种 COVID-19 疫苗的理性思考。
Prenat Diagn. 2021 Jul;41(8):1018-1035. doi: 10.1002/pd.5985. Epub 2021 Jun 30.
Zotero 插件